ArticleRheumatology international2026
Stress exposure prior to diagnosis and clinical characteristics in systemic lupus erythematosus: a cross-sectional study.
Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychological stress has been linked to the onset and course of autoimmune diseases. However, limited data exist regarding the relationship between pre-diagnosis stress exposure and subsequent disease course in systemic lupus erythematosus (SLE). We evaluated the association between psychological stress prior to SLE diagnosis and subsequent disease characteristics. We conducted a cross-sectional study of adults with SLE treated at a tertiary hospital between November 2019 and December 2022. Stress exposure during the two years preceding SLE diagnosis was assessed using the Holmes-Rahe Social Readjustment Rating Scale (life change units, LCU), and categorized as low (< 150), intermediate (150-299), or high (≥ 300). Data on clinical manifestations, comorbidities, disease activity patterns, patient-reported outcomes, and organ damage were collected. Associations between stress levels and outcomes were analyzed using logistic regression models. A total of 140 patients were included (90.7% female; median age at diagnosis 35.5 years). Moderate-to-high stress exposure (LCU ≥ 150) was reported by 46% of patients. Compared with low stress exposure (< 150 LCU), high stress exposure (≥ 300 LCU) was associated with significantly higher rates of depression (62.5% vs. 28.0%; p = 0.002), hypertension (54.2% vs. 24.0%, p = 0.006), and obesity (12.5% vs. 0.0%, p = 0.013), as well as greater fatigue burden (median 68.7 vs. 46.9, p = 0.005). High stress exposure was associated with antiphospholipid syndrome (OR 6.3, 95% CI 1.4-28.8), depression (OR 4.3, 95% CI 1.6-11.3), and a lower likelihood of long quiescent disease course (OR 0.22, 95% CI 0.07-0.7). Patients with higher stress exposure more frequently believed that stress contributed to both disease onset (100% vs. 71.7%, p = 0.006) and flares (100% vs. 69%, p = 0.006). Elevated stress levels preceding SLE diagnosis are associated with comorbidities and less favorable disease patterns. These findings underscore the clinical relevance of psychological stress in SLE and support the need for prospective studies examining its relationship with disease course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.